Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variantShuai Xia, Shibo Jiang, Qiaoshuai Lan et al.|Cell Research|2022Cited by 40
Human respiratory organoids sustained reproducible propagation of human rhinovirus C and elucidation of virus-host interactionCun Li, Jie Zhou, Yifei Yu et al.|Nature Communications|2024Cited by 20
Organoid-based neutralization assays reveal a distinctive profile of SARS-CoV-2 antibodies and recapitulate the real-world efficacyZhixin Wan, Jie Zhou, Cun Li et al.|Proceedings of the National Academy of Sciences|2025Cited by 5